$3.83
1.06%
NYSE, Sep 12, 10:00 pm CET
ISIN
US90400P1012
Symbol
UGP

Ultrapar Participacoes S.A. Sponsored ADR Stock price

$3.84
+0.64 20.00% 1M
+1.11 40.66% 6M
+1.21 46.01% YTD
-0.25 6.11% 1Y
+1.14 42.22% 3Y
-0.36 8.57% 5Y
-4.75 55.27% 10Y
+1.77 85.06% 20Y
NYSE, Closing price Fri, Sep 12 2025
+0.05 1.32%
ISIN
US90400P1012
Symbol
UGP
Sector

Key metrics

Basic
Market capitalization
$4.2b
Enterprise Value
$6.5b
Net debt
$2.3b
Cash
$511.4m
Shares outstanding
1.1b
Valuation (TTM | estimate)
P/E
10.1 | 11.9
P/S
0.2 | 0.2
EV/Sales
0.3 | 0.2
EV/FCF
14.1
P/B
1.5
Dividends
DPS
$0.12
Yield 1Y | 5Y
3.2% | 2.9%
Growth 1Y | 5Y
-5.6% | 4.4%
Payout 1Y | 3Y
33.6% | 27.6%
Increased
0 Years
Financials (TTM | estimate)
Revenue
$25.5b | $26.3b
EBITDA
$1.2b | $1.1b
EBIT
$919.7m | $818.9m
Net Income
$423.0m | $346.7m
Free Cash Flow
$461.3m
Growth (TTM | estimate)
Revenue
8.4% | 5.6%
EBITDA
4.3% | -2.4%
EBIT
3.8% | -10.6%
Net Income
-13.2% | -21.5%
Free Cash Flow
-4.9%
Margin (TTM | estimate)
Gross
7.2%
EBITDA
4.5% | 4.2%
EBIT
3.6%
Net
1.7% | 1.3%
Free Cash Flow
1.8%
Financial Health
Equity Ratio
38.3%
Return on Equity
15.6%
ROCE
16.7%
ROIC
10.0%
Debt/Equity
1.0
More
EPS
$0.4
FCF per Share
$0.4
Short interest
0.4%
Employees
10k
Rev per Employee
$2.6m
Show more

Is Ultrapar Participacoes S.A. Sponsored ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,008 stocks worldwide.

Ultrapar Participacoes S.A. Sponsored ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

22 Analysts have issued a Ultrapar Participacoes S.A. Sponsored ADR forecast:

16x Buy
73%
5x Hold
23%
1x Sell
5%

Analyst Opinions

22 Analysts have issued a Ultrapar Participacoes S.A. Sponsored ADR forecast:

Buy
73%
Hold
23%
Sell
5%

Financial data from Ultrapar Participacoes S.A. Sponsored ADR

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
25,490 25,490
8% 8%
100%
- Direct Costs 23,665 23,665
9% 9%
93%
1,825 1,825
1% 1%
7%
- Selling and Administrative Expenses 837 837
4% 4%
3%
- Research and Development Expense - -
-
-
1,151 1,151
4% 4%
5%
- Depreciation and Amortization 231 231
6% 6%
1%
EBIT (Operating Income) EBIT 920 920
4% 4%
4%
Net Profit 423 423
13% 13%
2%

In millions USD.

Don't miss a Thing! We will send you all news about Ultrapar Participacoes S.A. Sponsored ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Ultrapar Participacoes S.A. Sponsored ADR Stock News

Neutral
Seeking Alpha
about one month ago
Ultrapar Participações S.A. (NYSE:UGP ) Q2 2025 Earnings Conference Call August 14, 2025 10:00 AM ET Company Participants Alexandre Mendes Palhares - Chief Financial & Investor Relations Officer Fulvius Tomelin - Corporate Participant Leonardo Linden - Corporate Participant Rodrigo de Almeida Pizzinatto - CEO & Member of Executive Board Tabajara Bertelli - Corporate Participant Conference Cal...
Neutral
Seeking Alpha
4 months ago
Ultrapar Participações S.A. (NYSE:UGP ) Q1 2025 Earnings Conference Call May 8, 2025 10:00 AM ET Company Participants Rodrigo Pizzinatto - Chief Executive Officer Alexandre Palhares - Chief Financial and Investor Relations Officer Leonardo Linden - Chief Executive Officer of Ipiranga Conference Call Participants Gabriel Barra - Citigroup Inc. Monique Greco - Itaú Rodolfo De Angele - JPMorgan Ch...

Company Profile

Ultrapar Participaçoes SA engages in the distribution and retail services including, fuel; liquefied petroleum gas (LPG); retail pharmacy; specialty chemicals, and liquid bulk storage businesses. It operates through the following segments: Ultragaz, Ipiranga, Oxiteno, Ultracargo, Extrafarma, and Others. The Ultragaz segment distributes LPG to residential, commercial, and industrial consumers. The Ipiranga segment operates the distribution and marketing of gasoline, ethanol, diesel, fuel oil, kerosene, natural gas for vehicles, and lubricants and related activities. The Oxiteno segment produces ethylene oxide and its main derivatives and fatty alcohols. The Extrafarma segment trades pharmaceutical, hygiene, and beauty products. The Other segment includes the parent company and subsidiaries Serma-Associação dos Usuários de Equipamentos de Processamento de Dados e Serviços Correlatos and Imaven Imóveis Ltda. The company was founded in 1937 and is headquartered in Sao Paulo, Brazil.

Head office Brazil
CEO Rodrigo Pizzinatto
Employees 9,558
Founded 1937
Website www.ultra.com.br

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today